Aims-To examine the immunohistochemical distribution of thymidine phosphorylase (TP) in all clinicopathological subtypes of Kaposi sarcoma. Methods-Thirty two biopsy specimens of Kaposi sarcoma (29 patients) were studied. Six of these patients represented classic, six endemic, eight HIV associated, seven post-immunosuppressionltransplant related, and two unclassifed variants of Kaposi sarcoma. The average age was 49 years (range 22-83 years) and the male: female ratio 24:5. Four samples of angiosarcoma and one ofspindle cell haemangioendothelioma were stained in parallel. All specimens were fixed in formalin, embedded in paraffin wax and processed routinely. Immunohistochemistry was carried out using an antibody directed against CD31 (JC70) and the monoclonal antibody P-GF.44C against TP.
Thymidine phosphorylase (TP) (previously known as platelet derived endothelial cell growth factor (PD-ECGF)) has been shown to be an angiogenic factor in both in vivo assays and in tumour systems.' TP is a single chain acidic polypeptide with a relative molecular mass of 45 ooo.2 TP catalyses breakdown of thymidine to deoxyribose-l-phosphate and thymine. Deoxyribose displays angiogenic activity in the chick chorioallantoic membrane (CAM assay).3 TP is postulated to promote endothelial cell proliferation by reducing thymidine concentrations which would otherwise inhibit endothelial cell growth. 4 Increased TP activity, therefore, could promote endothelial cell growth and increased production of deoxyribose, with subsequent promotion of angiogenesis.
In normal human tissues TP is expressed in endothelial cells, macrophages, stromal cells, glial cells, and epithelia such as skin, salivary gland and breast, where it is involved in normal cellular differentiation and maturation.' In non-neoplastic conditions TP plays a role in endothelial repair and angiogenesis associated with wound healing. 5 Increased TP expression also occurs in areas of angiogenesis within tumours. In breast and ovarian cancer, angiogenesis is associated with up-regulation of TP activity. 6 cutaneous origin (one each involving the following sites: deep soft tissue, hard and soft palate and liver). Four samples ofangiosarcoma and one ofspindle cell haemangioendothelioma were stained in parallel to compare staining patterns ofknown vascular neoplasms with that of Kaposi sarcoma, a putative vascular tumour. All cases were fixed in formalin, embedded in paraffin wax and processed routinely. Haematoxylin and eosin sections were evaluated to confirm the histological diagnoses. Immunohistochemistry was performed on the paraffin wax embedded tissue sections using antibodies directed against CD3 1 (JC70) (Dako, High Wycombe, UK) and the monoclonal antibody P-GF.44C, directed against TP.1 Both antibodies were used as neat supernatant. A two step technique using biotinylated goat anti-mouse immunoglobulin and ABC horse radish peroxidase was used for staining with P-GF.44C and JC70. Diaminobenzidine 
